Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62131 | 0.81 | BLM (0.46) | BLMLMNAPTPN1MEN1KMT2A | |
| SCHEMBL5144765 | 0.78 | BLM (0.50) | BLMLMNAPTPN1ANPEPRNPEP | |
| SCHEMBL5144576 | 0.78 | BLM (0.50) | BLMLMNAPTPN1ANPEPRNPEP | |
| SCHEMBL11501644 | 0.77 | LMNA (0.52) | BLMLMNAPTPN1MEN1KMT2A | |
| SCHEMBL27656888 | 0.77 | BLM (0.42) | BLMLMNAEPHX1PTPN1ANPEP | |
| SCHEMBL11168376 | 0.76 | EPHX1 (0.53) | BLMEPHX1ANPEPRNPEPDNPEP | |
| SCHEMBL2824432 | 0.76 | ANPEP (0.55) | LMNAEPHX1ANPEPRNPEPDNPEP | |
| SCHEMBL12164496 | 0.75 | BLM (0.47) | BLMLMNAPTPN1ANPEPRNPEP | |
| SCHEMBL5144491 | 0.75 | BLM (0.43) | BLMLMNAPTPN1ANPEPRNPEP | |
| SCHEMBL12164429 | 0.74 | BLM (0.46) | BLMLMNAPTPN1ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101538200-A | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants | FH FAULDING & CO LTD (AU) | 2009-09-23 | — | — | CN | disclosed |
| EP-1534669-A4 | UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS | MAYNE PHARMA INT PTY LTD (AU) | 2007-03-14 | — | — | EP | disclosed |
| US-20050249665-A1 | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants | DBL AUSTRALIA PTY LTD. (AU) | 2005-11-10 | — | — | US | disclosed |
| CN-1694865-A | Urea, glycerate and hydroxylamine headed hydrocarbon chain lyotropic phase forming surfactants | DBL AUSTRALIA PTY LTD (AU) | 2005-11-09 | — | — | CN | disclosed |
| EP-1534669-A1 | UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS | DBL Australia PTY. LTD. (AU) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004022530-A1 | UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS | DBL AUSTRALIA PTY LTD (AU) | 2004-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249665-A1 | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants | LIPA, HDHD5, UGCG | BLM 1559/4885LMNA 208/4885EPHX1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.